Diabetic cardiomyopathy: Where are we 40 years later?
- 31 March 2006
- journal article
- review article
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 22 (4), 305-308
- https://doi.org/10.1016/s0828-282x(06)70914-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Oxidative stress and stress signaling: menace of diabetic cardiomyopathyActa Pharmacologica Sinica, 2005
- Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic CardiomyopathyCirculation, 2005
- Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative Stress, Remodeling, and Endothelial-Myocyte UncouplingJournal of Cardiovascular Pharmacology and Therapeutics, 2005
- Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetesCanadian Journal of Physiology and Pharmacology, 2004
- Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic ImplicationsEndocrine Reviews, 2004
- What Is the Role of β-Adrenergic Signaling in Heart Failure?Circulation Research, 2003
- The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolismProstaglandins, Leukotrienes & Essential Fatty Acids, 1999
- Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor αOnline Journal of Public Health Informatics, 1998
- Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic ratsDiabetes, 1988
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972